Overweight
Showing NaN - NaN of 39
Type 2 Diabetes, Obesity, Overweight Trial in Worldwide (Retatrutide, Placebo)
Not yet recruiting
- Type 2 Diabetes
- +3 more
- Retatrutide
- Placebo
-
Los Angeles, California
- +91 more
Jul 10, 2023
Obesity, Overweight Trial in Puerto Rico, United States (Tirzepatide, Semaglutide 2.4 mg)
Recruiting
- Obesity
- Overweight
- Tirzepatide
- Semaglutide 2.4 mg
-
Birmingham, Alabama
- +31 more
Apr 26, 2023
Type 2 Diabetes, Obesity, Overweight or Obesity Trial in Worldwide (Orforglipron, Insulin Glargine)
Recruiting
- Type 2 Diabetes
- +5 more
- Orforglipron
- Insulin Glargine
-
Muscle Shoals, Alabama
- +320 more
Apr 12, 2023
Overweight, Obesity and Diabetes, Type 2 Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)
Not yet recruiting
- Overweight
- +2 more
- Cagrilintide
- +3 more
-
Concord, California
- +147 more
Jan 24, 2023
Overweight, Obesity Trial (Semaglutide, Placebo semaglutide)
Active, not recruiting
- Overweight
- Obesity
- Semaglutide
- Placebo semaglutide
-
Birmingham, Alabama
- +21 more
Jan 24, 2023
Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Overweight
- Obesity
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +804 more
Dec 19, 2022
Overweight, Obesity Trial in Worldwide (Gelesis100, )
Completed
- Overweight
- Obesity
- Gelesis100
- placebo
-
Anaheim, California
- +35 more
Aug 8, 2022
Obesity, Overweight Trial in Puerto Rico, United States (LY3437943, Placebo)
Active, not recruiting
- Obesity
- Overweight
- LY3437943
- Placebo
-
Scottsdale, Arizona
- +27 more
May 10, 2022
Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide), Liraglutide)
Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)
Active, not recruiting
- Type 2 Diabetes
- +2 more
- Tirzepatide
- Placebo
-
Birmingham, Alabama
- +74 more
Apr 18, 2022
Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)
Active, not recruiting
- Overweight
- Obesity
- Tirzepatide
- Placebo
-
Pelham, Alabama
- +119 more
Apr 12, 2022
Pulmonary Disease, Chronic Obstructive, Obesity, Weight Loss Trial in United States (Lifestyle Intervention)
Completed
- Pulmonary Disease, Chronic Obstructive
- +4 more
- Lifestyle Intervention
-
Birmingham, Alabama
- +38 more
Mar 10, 2022
Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)
Active, not recruiting
- Obesity
- Overweight
- Tirzepatide
- Placebo
-
Huntington Park, California
- +64 more
Mar 22, 2022
Overweight, Obesity Trial in United States
Recruiting
- Overweight
- Obesity
-
Little Rock, Arkansas
- +27 more
Feb 11, 2022
Obesity, Overweight Trial in Worldwide (Oral semaglutide, Placebo (semaglutide))
Active, not recruiting
- Obesity
- Overweight
- Oral semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +50 more
Jan 26, 2022
Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide))
Completed
- Overweight
- Obesity
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +40 more
Nov 10, 2021
Obesity, Overweight Trial in Worldwide (Semaglutide 1.0 mg, Semaglutide 2.4 mg, Placebo I (Semaglutide))
Completed
- Obesity
- Overweight
- Semaglutide 1.0 mg
- +3 more
-
Buena Park, California
- +146 more
Nov 8, 2021